Similar articles

• Dopaminergic regulation of aldosterone secretion. Biochemical mechanisms and pharmacology.

  Missale C, Lombardi C, Sigala S, Spano PF. Missale C, et al. Am J Hypertens. 1990 Jun;3(6 Pt 2):93S-95S. doi: 10.1093/ajh/3.6.93s. Am J Hypertens. 1990. PMID: 2166536 Review.
• Effects of dopamine, high potassium concentration and field stimulation on the secretion of aldosterone by the perfused rat adrenal gland.

  Porter ID, Whitehouse BJ, Price GM, Hinson JP, Vinson GP. Porter ID, et al. J Endocrinol. 1992 May;133(2):275-82. doi: 10.1677/joe.0.1330275. J Endocrinol. 1992. PMID: 1613429
• Dopaminergic control of aldosterone secretion. State-of-the-art review.

  Cuche JL. Cuche JL. Fundam Clin Pharmacol. 1988;2(4):327-39. doi: 10.1111/j.1472-8206.1988.tb00644.x. Fundam Clin Pharmacol. 1988. PMID: 2906035 Review. No abstract available.
• [Mechanism of sodium retention in nephrotic syndrome: role of aldosterone and glomerular filtration].

  Reubi FC, Weidmann P. Reubi FC, et al. J Urol Nephrol (Paris). 1978 Sep;84(9):643-6. J Urol Nephrol (Paris). 1978. PMID: 748584 French. No abstract available.
• Involvement of dopamine receptor subtypes in dopaminergic modulation of aldosterone secretion in rats.

  Barrett RJ, Wright KF, Taylor DR, Proakis AG. Barrett RJ, et al. Life Sci. 1987 Apr 13;40(15):1499-506. doi: 10.1016/0024-3205(87)90382-1. Life Sci. 1987. PMID: 2951574